Gastrointestinal Sciences - Chronic visceral pain, microbiome My laboratory is interested in the role of the microbiome in chronic visceral and somatic pain. This pertains to disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Over twenty percent of patients with IBD continue to experience chronic abdominal pain despite achieving mucosal healing on endoscopy. Chronic abdominal pain is a devastating symptom, resulting in high levels of anxiety, depression and poor quality of life in IBD patients. Unfortunately, effective treatments for chronic pain are limited. At present, it is estimated that 5-25% of IBD outpatients are on chronic narcotic therapy, which is not only ineffectual but can worsen abdominal pain and increase the risk of death. Our overall goal is to develop innovative approaches to the treatment of chronic pain in IBD, thus improving quality of life and preventing the use of chronic narcotic therapy.
This supervisor is currently accepting inquires.
Please note that I will not be accepting students until January 2018. I am looking for motivated, hard-working individuals who have a passion for research.
Complete the following form if you are interested in working with this Supervisor for your Graduate Program:
All fields are required, unless indicated otherwise.